Back
Freeport-McMoRan Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Buy
53
FCX
Freeport-McMoRan
Last Price:
$40.94
Seasonality Move:
-0.8%
Buy
56
ALNY
Alnylam Pharmaceuticals
Last Price:
$307.92
Seasonality Move:
21.88%
Buy
53
Freeport-McMoRan (FCX)
is a Buy
Is Freeport-McMoRan a Buy, Sell or Hold?
-
The current Freeport-McMoRan [FCX] share price is $41.18. The Score for FCX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
FCX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
56
Alnylam Pharmaceuticals (ALNY)
is a Buy
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $304.67. The Score for ALNY is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FCX Stock Price Chart
What is Freeport-McMoRan's stock price today?
-
The Freeport-McMoRan share price today is $41.18The current trend is moderately bullish and FCX is experiencing slight buying pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $304.67Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.
FCX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.13 | Buy |
Relative Strength Index (14 RSI): | 59.63 | Buy |
Chaikin Money Flow: | 2668852 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (38.11 - 40.97) | Buy |
Bollinger Bands (100): | (34.97 - 40.35) | Buy |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 9.67 | Buy |
Relative Strength Index (14 RSI): | 62.21 | Buy |
Chaikin Money Flow: | 453208 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (274.26 - 305.32) | Buy |
Bollinger Bands (100): | (242.96 - 286.12) | Buy |
FCX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 41.37 | Sell |
20-day SMA: | 39.78 | Buy |
50-day SMA: | 37.09 | Buy |
200-day SMA: | 40.86 | Buy |
8-day EMA: | 41.12 | Buy |
20-day EMA: | 40.05 | Buy |
50-day EMA: | 38.68 | Buy |
200-day EMA: | 40.06 | Buy |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 303.45 | Buy |
20-day SMA: | 296.53 | Buy |
50-day SMA: | 268.51 | Buy |
200-day SMA: | 263.37 | Buy |
8-day EMA: | 301.81 | Buy |
20-day EMA: | 294.18 | Buy |
50-day EMA: | 278.6 | Buy |
200-day EMA: | 255.58 | Buy |
Freeport-McMoRan Earnings Growth & FCX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.07 per share, an increase this year of $0.20 per share, and an increase next year of $0.54 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.04 per share, an increase next quarter of $1.63 per share, an increase this year of $1.19 per share, and an increase next year of $3.19 per share.
Freeport-McMoRan Technical Analysis
May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
30 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
30 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |